Biolase (BLTI)
Symbol Info
Listed Symbol BLTI
Name Biolase
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $
Price Info
21 Day Moving Average $-
21 Day EMA $-
50 Day Moving Average $-
50 Day EMA $-
200 Day EMA $-
200 Day Moving Average -
52 Week High $
52 Week Low $-
52 Week Change $
Alpha
Beta
Standard Deviation
R2
Periods
Share Information
10 Day Average Volume -
20 Day Average Volume -
30 Day Average Volume -
50 Day Average Volume -
Outstanding Shares 21,866,197
Float Shares 18,347,409
Percent Float 83.91%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 38
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 1,157,080
Institute Holdings Percent 42.200000
Institute Sold Previous 3 Months 1,002,288
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 7
Insider Holdings Percent 16.10%
Insider Sold Previous 3 Months 7
Insiders Shares Owned 3,518,788
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $-
21 Day Percent Change -
30 Day Price Change $-
30 Day Percent Change -
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $-
90 Day Percent Change -
Quarter To Date $-
Quarter To Date Percent -
180 Day Price Change $-
180 Day Percent Change -
200 Day Price Change $-
200 Day Percent Change -
Year To Date $-
Year To Date Percent -
Profile
Description Biolase Inc is a US-based medical device company. It develops, manufactures, markets and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products i.e. Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Details
Issue Type CS
Market Cap $-
Sec Type EQS
Auditor BDO USA, LLP
Total Shares Outstanding 21,866,197
CEO Todd A. Norbe
Employees 190
Last Audit UE
Classification
CIK 0000811240
Industry Medical Devices
Sector Healthcare
NAICS Dental Equipment and Supplies Manufacturing(339114)
Info
Address 4 Cromwell
Irvine, CA 92618
Website http://www.biolase.com
Facisimile +1 949 273-6677
Telephone +1 949 361-1200
Email rcaron@dresnerallencaron.com
Key Ratios
Profitability
EBIT Margin -43.9
EBITDA Margin -41.6
Pre-Tax Profit Margin -38.8
Profit Margin Cont -47.46
Gross Margin 38.30
Profit Margin TOT -47.46
Income Statements
Revenue $-
Revenue Per Share $1.9643
Revenue 3 Years $-4.54
Revenue 5 Years $-1.58
Valuation Measures
PE Ratio -
Enterprise Value $-
Price To Sales -
Price To Free Cash -1.7
PE High Last 5 Years -
Price To Book 5.9
Price To Cash Flow 23.6
PE Low Last 5 Years -
Price To Tangible Book 26.0
Financial Strength
Total Debt To Equity 3.7
Int Coverage -12.8
Current Ratio 2.0
Leverage Ratio 3.6
Quick Ratio 1.0
Long Term Debt To Capital 0.78
Assets
Receivables Turnover 1.7
Invoice Turnover 2.00
Assets Turnover 0.50
Management Effectiveness
Return Assets -59.94
Return On Equity -168.58
Return On Capital -97.69
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type Stock


Your Recent History
NASDAQ
BLTI
Biolase
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.